| Attributes | Values |
|---|
| rdf:type
| |
| description
| - wetenschappelijk artikel (nl)
- наукова стаття, опублікована в травні 2012 (uk)
- im Mai 2012 veröffentlichter wissenschaftlicher Artikel (de)
- artículu científicu espublizáu en mayu de 2012 (ast)
- scientific article published on 01 May 2012 (en)
|
| publication date
| |
| publication date
| |
| author name string
| |
| author name string
| - Antonio L Dans
- Peter Sleight
- Salim Yusuf
- Matyas Keltai
- Giuseppe Mancia
- Gilles Dagenais
- Gianluca Iacobellis
- Paolo Verdecchia
- Peggy Gao
- Azan S Binbrek
- Rafael Ferreira
- Jeff Healey
- Nicolaas Holwerda
- Nicholas Karatzas
- Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint TrialTelmisartan Randomized AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease Investigators
|
| rdfs:label
| - Blood pressure and other determinants of new-onset atrial fibrillation in patients at high cardiovascular risk in the Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNt Study in ACE iNto (en)
- Blood pressure and other determinants of new-onset atrial fibrillation in patients at high cardiovascular risk in the Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNt Study in ACE iNto (nl)
|
| skos:prefLabel
| - Blood pressure and other determinants of new-onset atrial fibrillation in patients at high cardiovascular risk in the Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNt Study in ACE iNto (en)
- Blood pressure and other determinants of new-onset atrial fibrillation in patients at high cardiovascular risk in the Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNt Study in ACE iNto (nl)
|
| name
| - Blood pressure and other determinants of new-onset atrial fibrillation in patients at high cardiovascular risk in the Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNt Study in ACE iNto (en)
- Blood pressure and other determinants of new-onset atrial fibrillation in patients at high cardiovascular risk in the Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNt Study in ACE iNto (nl)
|
| author
| |
| author
| |
| title
| |
| title
| - Blood pressure and other determinants of new-onset atrial fibrillation in patients at high cardiovascular risk in the Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease studies (en)
|
| page(s)
| |
| page(s)
| |
| instance of
| |
| instance of
| |
| main subject
| |
| main subject
| |
| PubMed ID
| |
| PubMed ID
| |
| PubMed ID
| |
| published in
| |
| published in
| |
| issue
| |
| volume
| |
| issue
| |
| volume
| |
| DOI
| |
| DOI
| |
| DOI
| - 10.1097/HJH.0B013E3283522A51
|
| is about
of | |
| is cites work
of | - What do we actually know about the relationship between arterial hypertension and atrial fibrillation?
- Associations of obesity and body fat distribution with incident atrial fibrillation in the biracial health aging and body composition cohort of older adults
- Effect of telmisartan on atrial fibrillation recurrences in patients with hypertension: a systematic review and meta-analysis
- Body fat, body fat distribution, lean body mass and atrial fibrillation and flutter. A Danish cohort study
- Relation of systolic, diastolic, and pulse pressures and aortic distensibility with atrial fibrillation (from the Multi-Ethnic Study of Atherosclerosis)
- What do we currently know about metabolic syndrome and atrial fibrillation?
- Understanding and treating hypertension in diabetic populations
- The association between insulin resistance and atrial fibrillation: A cross-sectional analysis from SPRINT (Systolic Blood Pressure Intervention Trial).
- Associations of Abdominal Obesity and New-Onset Atrial Fibrillation in the General Population.
- Hypertension and Atrial Fibrillation: An Intimate Association of Epidemiology, Pathophysiology, and Outcomes
- Obesity, metabolic syndrome and risk of atrial fibrillation: a Swedish, prospective cohort study
- Invited review: hypertension and atrial fibrillation: epidemiology, pathophysiology, and implications for management
- Acute Tachycardia Increases Aortic Distensibility, but Reduces Total Arterial Compliance Up to a Moderate Heart Rate
- Consensus document on hypertension and cardiac arrhythmias.
- Effects of telmisartan on vascular endothelial function, inflammation and insulin resistance in patients with coronary heart disease and diabetes mellitus.
- Measures of Body Size and Composition and Risk of Incident Atrial Fibrillation in Older People: The Cardiovascular Health Study
- Anthropometric parameters and the incidence of atrial fibrillation in older people: the PRO.V.A study
- Pulse pressure is not an independent predictor of incident atrial fibrillation in 60-year-old men and women
- Reactive Hyperemia Index Associated With Atherosclerotic Cardiovascular Disease Under Treatment for Lifestyle Diseases
|
| is cites work
of | |
![[RDF Data]](/fct/images/sw-rdf-blue.png)
![[cxml]](/fct/images/cxml_doc.png)
![[csv]](/fct/images/csv_doc.png)
![[text]](/fct/images/ntriples_doc.png)
![[turtle]](/fct/images/n3turtle_doc.png)
![[ld+json]](/fct/images/jsonld_doc.png)
![[rdf+json]](/fct/images/json_doc.png)
![[rdf+xml]](/fct/images/xml_doc.png)
![[atom+xml]](/fct/images/atom_doc.png)
![[html]](/fct/images/html_doc.png)